Sponsored research vs. stock promotion.

From the outside they can look identical: a positive write-up about a small company, paid for by that company. The law, and the SEC, treat them as opposites. The difference comes down to two things.

Why they get confused.

The confusion is understandable, because the surface facts are the same in both cases. A company pays money. A favorable piece about that company appears. An investor reads it. If that were the whole story, there would be no way to tell them apart, and an investor-relations team would be right to worry that any paid coverage looks like promotion.

But the surface is not where the distinction lives. It lives in two questions: was the payment disclosed, and is the content honest. Those two questions separate a long-established lawful practice from the conduct the SEC has repeatedly charged. The legal foundation for the first question is covered in detail in is sponsored research legal; this page is about telling the two apart in practice.

The two profiles, side by side.

The red flags of promotion.

The SEC has been explicit that micro-cap stocks are especially exposed to schemes that dress paid promotion up as unbiased commentary. In its 2017 enforcement sweep, the agency described campaigns of more than 250 articles that left investors believing they were reading independent analysis when the writers were secretly paid, and some pieces went so far as to falsely claim no compensation had been received. The warning signs are consistent:

• Guaranteed or explosive returns. Language about a stock that is about to multiply. Real research describes a business; it does not promise an outcome.
• Urgency and pressure. Buy now, before it runs. Manufactured time pressure is a sales tactic, not analysis.
• No risk anywhere. A write-up with only upside and no honest discussion of what could go wrong is an advertisement.
• Missing or vague disclosure. No statement of who paid, how much, or in what form. Or a disclosure so buried and generic it tells you nothing.
• False independence. Material that presents itself as objective commentary while the compensation is hidden. This is the exact conduct the SEC charged.
• It vanishes. Content built for a campaign window disappears once the window closes, leaving nothing behind.

The markers of legitimate research.

The opposite profile is just as recognizable, and it is what an issuer should insist on before commissioning anything:

• A complete disclosure on every report. The fact of payment, the source, the amount, and the form, placed with the research itself.
• Risks named in the text. A credible report says what could break the thesis, not just what supports it.
• No promises about the market. No price targets, no volume claims, no representations about investor demand.
• No coordination with a financing. The research is not timed to or tied to a raise. A firm offering to drive interest ahead of one is the red flag your counsel should hear about.
• A durable, documented deliverable. Something that remains discoverable and stands as a record, rather than a blast that expires.
• A disclosed or absent position. A provider that holds no stake in the covered stock has no way to profit from a short-term move.

A practical test for an IR team.

If you are evaluating a coverage provider, the questions that matter are simple, and the answers are quick to verify:

• Will the compensation be disclosed in full, on every report, in a form my legal team can review before publication?
• Does the research name risks, or is it all upside?
• Does the provider make any representation about share price, volume, or demand? It should not.
• Does the provider hold a position in covered companies, and will it say so?
• Is the deliverable permanent and documented, or a short promotional burst?

A provider that answers those cleanly is offering research. A provider that dodges them is offering something else.

Frequently asked questions.

Sponsored research is documented analysis that discloses how it was funded and tells the truth about the company, including its risks. Stock promotion is a paid campaign designed to move a share price in the short term, often disguised as independent opinion and frequently making claims about price or returns. The legal dividing line is disclosure and honesty: disclosed, accurate research is lawful, while concealed or misleading promotion is what the SEC pursues.

No, not when it is done correctly. A pump and dump uses hype to inflate a price so insiders can sell into the spike. Legitimate sponsored research makes no price or volume promises, discloses its compensation, and does not coordinate with anyone selling shares. A provider that holds no position in the covered stock has no way to profit from a short-term move, which removes the incentive at the center of a pump and dump.

Common red flags include claims of guaranteed or explosive returns, urgency and pressure to act now, no discussion of risk, missing or vague compensation disclosure, content presented as independent while secretly paid for, and material that disappears after a short campaign window. The SEC has warned that micro-cap stocks are especially exposed to schemes that present paid promotion as unbiased commentary.

Work only with a provider that publishes a full Section 17(b) disclosure on every report, that names risks rather than hiding them, that makes no representations about share price or trading volume, that does not coordinate with a financing, and that can produce its disclosure for your legal team to review before anything publishes. The deliverable should be durable, documented research, not a time-limited advertisement.

Explore the platform